WHO authorizes Ebola vaccine trials for DRC Bundibugyo outbreak
The World Health Organization has authorized clinical trials for two new Ebola vaccines, ChAdOx1 BDBV and mRNA-1469, to address the ongoing outbreak in the Democratic Republic of Congo. These candidates specifically target the Bundibugyo virus, a strain not covered by the existing Ervebo vaccine, as health officials struggle to contain an epidemic that has claimed … Read more